CAS 31542-63-9
:1,3-Dipropil-7-metilxantina
- 1,3-Dipropylheteroxanthine
- 1H-Purine-2,6-dione, 3,7-dihydro-7-methyl-1,3-dipropyl-
- 3,7-Dihydro-7-methyl-1,3-dipropyl-1H-purine-2,6-dione
- 7-Methyl-1,3-dipropylxanthine
- 7-methyl-1,3-dipropyl-3,7-dihydro-1H-purine-2,6-dione
- Heteroxanthine, 1,3-dipropyl-
- Sc 5192
- (1,3)-Dipropyl-7-methylxanthine
7-Methyl-1,3-dipropyl-1H-purine-2,6(3H,7H)-dione
CAS:Formula:C12H18N4O2Colore e forma:SolidPeso molecolare:250.29691,3-Dipropyl-7-methylxanthine
CAS:Prodotto controllatoApplications A phosphodiesterase inhibitor and caffeine analog with some selectivity for A2 adenosine receptors. UV lmax = 273 nm, log e=3.98.
References Clark, K., et al.: J. Physiol., 481, 129 (1994), Liu, W., et al.: Pharmacol., 54, 135 (1997), Zarrindast, M., et al.: Eur. Neuropsychopharmacol., 13, 165 (2003), Malki, A., et al.: Exp. Oncol., 28, 16 (2006),Formula:C12H18N4O2Colore e forma:NeatPeso molecolare:250.301,3-Dipropyl-7-methylxanthine
CAS:Prodotto controllato1,3-Dipropyl-7-methylxanthine is a xanthine compound that is structurally related to caffeine. It has been shown to have an inhibitory effect on the production of reactive oxygen species and cytosolic calcium levels in primary cells, as well as a nonselective adenosine receptor antagonist activity. It has also been shown to antagonize the effects of adenosine receptors, p2 receptors, and p2y receptors. This drug is used for the treatment of basophilic leukemia.
Formula:C12H18N4O2Purezza:Min. 95%Peso molecolare:250.3 g/mol



